Safety profile and normalization of glycemia of 14 % peripheral dextrose infusion: a prospective observational study

Authors

DOI:

https://doi.org/10.32645/13906984.1432

Keywords:

Newborn, neonatal hypoglycemia, phlebitis, peripheral catheter, dextrose

Abstract

Neonatal hypoglycemia is the leading cause of hospitalization in newborns. The objective of this study was to describe the effect of peripheral infusion of 14% dextrose on normalizing blood glucose and its safety profile. A prospective, single-cohort study was conducted, including episodes of 14% dextrose infusion through a peripheral catheter. A total of 92 infusion episodes in 40 patients were evaluated. The success rate was 97%. 59% required catheter removal: 32% due to infiltration, 25% due to dysfunction, and 3% due to phlebitis. The incidence density of phlebitis was 25 episodes/1000 catheter days. All cases occurred in patients weighing between 1,500 to 2,500 grams, with an incidence of 9.7%, compared to 3% in the total population. The incidence of phlebitis in full-term newborns was 2.4%, compared to 15% in premature infants. In those receiving other medications, the incidence of phlebitis was 6.6%, compared with 2.6% in the group that did not receive other medications, with an incidence ratio of 2.56. Catheter location did not affect the incidence of phlebitis. Peripheral infusion of 14% dextrose was shown to be effective in normalizing blood glucose, with a lower incidence of phlebitis than reported in the literature. Prematurity, low birth weight, and the administration of other medications are associated with a higher incidence of phlebitis.

Downloads

Download data is not yet available.

References

Adamkin, D. H. (2017). Neonatal hypoglycemia. Seminars in Fetal & Neonatal Medicine, 22(1), 36-41. https://doi.org/10.1016/j.siny.2016.08.007

Barría, P. R., & Santander, M. G. (2006). Acceso vascular periférico en neonatos de cuidado intensivo: Experiencia de un hospital público. Ciencia y Enfermería, 12(2), 17-24. http://dx.doi.org/10.4067/S0717-95532006000200005

Bell, E. F., & Acarregui, M. J. (2014). Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews, (12), 1-54. https://doi.org/10.1002/14651858.CD000376.pub3

Boluyt, N., van Kempen, A., & Offringa, M. (2006). Neurodevelopment after neonatal hypoglycemia: A systematic review and design of an optimal future study. Pediatrics, 117(6), 2231-2243. https://doi.org/10.1542/peds.2005-1919

Boullata, J. I., Gilbert, K., Sacks, G., Labossiere, R. J., Crill, C., & Goday, P. (2014). A.S.P.E.N. clinical guidelines. Journal of Parenteral and Enteral Nutrition, 38(3), 334-377. https://doi.org/10.1177/0148607114522045

Chesshyre, E., Goff, Z., Bowen, A., & Carapetis, J. (2015). The prevention, diagnosis and management of central venous line infections in children. Journal of Infection, 71(1), S59-S75. https://doi.org/10.1016/j.jinf.2015.02.006

Harris, D. L., Weston, P. J., & Harding, J. E. (2012). Incidence of neonatal hypoglycemia in babies identified as at risk. The Journal of Pediatrics, 161(5), 787-791. https://doi.org/10.1016/j.jpeds.2012.05.022

Hartman, C., et al. (2018). ESPGHAN/ESPEN/ESPR Guidelines on pediatric parenteral nutrition: complications. Clinical Nutrition, 37(6), 1761–1787. https://doi.org/10.1016/j.clnu.2018.06.956

Hospital Universitario San Ignacio. (2012, 10 de octubre). Hipoglicemia neonatal temprana [Guía de práctica clínica].

Kuwahara, T., Asanami, S., & Kubo, S. (1998). Experimental infusion phlebitis: Tolerance osmolality of peripheral venous endothelial cells. Nutrition, 14(6), 496-501. https://doi.org/10.1016/s0899-9007(98)00037-9

Lilien, L. D., Pildes, R. S., Srinivasan, G., Voora, S., & Yeh, T. F. (1980). Treatment of neonatal hypoglycemia with minibolus and intravenous glucose infusion. The Journal of Pediatrics, 97(2), 295-298. https://doi.org/10.1016/S0022-3476(80)80402-0

Milutinović, D., Simin, D., & Zec, D. (2015). Risk factor for phlebitis: A questionnaire study of nurses' perception. Revista Latino Americana de Enfermagem, 23(4), 677-684. https://doi.org/10.1590/0104-1169.0364.2646

Perlman, S. E., Saiman, L., & Larson, E. L. (2007). Risk factors for late onset healthcare–associated bloodstream infections in patients in neonatal intensive care units. American Journal of Infection Control, 35(3), 177-182. https://doi.org/10.1016/j.ajic.2006.06.007

Queensland Clinical Guidelines. (2022). Hypoglycaemia–newborn (Guideline No. MN(19).8 V11 R24). Queensland Health. https://www.health.qld.gov.au/__data/assets/pdf_file/0043/881899/g-hypogly.pdf

Rickard, C. M. (2013). Clinically indicated and routine replacement of peripheral IV catheters did not differ for phlebitis. Annals of Internal Medicine, 158(JC8), 1-47. https://doi.org/10.1002/14651858.cd007798.pub5

Sweet, B., Grayson, S., & Polak, M. (2013). Management strategies for neonatal hypoglycemia. Journal of Pediatric Pharmacology and Therapeutics, 18(3), 199-208. https://doi.org/10.5863/1551-6776-18.3.199

Ullman, A. J., Marsh, N., Mihala, G., et al. (2015). Complications of central venous access devices: A systematic review. Pediatrics, 136(6), e1331-e1344. https://doi.org/10.1542/peds.2015-0745

Van Donk, P., Rickard, C. M., McGrail, M. R., & Doolan, G. (2009). Routine replacement versus clinical monitoring of peripheral intravenous catheters in a regional hospital in the home program: A randomized controlled trial. Infection Control and Hospital Epidemiology, 30(9), 915-917. https://doi.org/10.1086/648546

Vanhatalo, T., & Tammela, O. (2010). Glucose infusions into peripheral veins in the management of neonatal hypoglycemia – 20% instead of 15%? Acta Pædiatrica, 99(3), 350-353. https://doi.org/10.1111/j.1651-2227.2009.01237.x

Vendramin, P. (2020). ResPeCt: Removal of peripheral intravenous catheters according to clinical signs or every 96 hours: Randomized, controlled and non inferiority trial. International Journal of Nursing Studies, 107, 103504. https://doi.org/10.1016/j.ijnurstu.2020.103504

Weston, P. J., Harris, D. L., Battin, M., Brown, J., Hegarty, J. E., & Harding, J. E. (2016). Oral dextrose gel for the treatment of hypoglycaemia in newborn infants. Cochrane Database of Systematic Reviews, 2016(5), CD011027. https://doi.org/10.1002/14651858.CD011027.pub2

Working Group of Pediatrics Chinese Society of Parenteral and Enteral Nutrition, Working Group of Neonatology Chinese Society of Pediatrics, & Working Group of Neonatal Surgery Chinese Society of Pediatric Surgery. (2013). CSPEN guidelines for nutrition support in neonates. Asia Pacific Journal of Clinical Nutrition, 22(4), 655-663. https://doi.org/10.6133/apjcn.2013.22.4.09

Published

2026-01-30

How to Cite

Safety profile and normalization of glycemia of 14 % peripheral dextrose infusion: a prospective observational study. (2026). Horizontes De Enfermería, 16(1), 40-50. https://doi.org/10.32645/13906984.1432